Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Zappulo

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
The New Microbiologica|May 29, 2023
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective studyBiagio Pinchera, Riccardo Scotto, Emanuela Zappulo, et al.
Transplantation|March 29, 2022
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center ExperienceBiagio Pinchera, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Multiple Sclerosis and Related Disorders|April 29, 2022
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosisEmanuela Zappulo, Antonio Riccardo Buonomo, Marcello Moccia, et al.
Cancers|July 12, 2025
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic CenterFrancesco Grimaldi, Mara Memoli, Simona Avilia, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center ExperienceIvan Gentile, Giulio Viceconte, Amedeo Lanzardo, et al.
Medical Mycology|February 13, 2019
Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannanMalgorzata Mikulska, Elisa Furfaro, Elena De Carolis, et al.
Journal of Clinical Medicine|December 19, 2020
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the IcebergNicola Capasso, Raffaele Palladino, Emma Montella, et al.
The New Microbiologica|April 30, 2019
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohortIvan Gentile, Antonio Riccardo Buonomo, Carmine Coppola, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 22, 2026
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort StudyAntonella d'Arminio Monforte, Nicolò Lentini, Alessandro Tavelli, et al.
Vaccines|December 23, 2022
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The New Microbiologica|May 29, 2023
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective studyBiagio Pinchera, Riccardo Scotto, Emanuela Zappulo, et al.
Transplantation|March 29, 2022
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center ExperienceBiagio Pinchera, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Multiple Sclerosis and Related Disorders|April 29, 2022
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosisEmanuela Zappulo, Antonio Riccardo Buonomo, Marcello Moccia, et al.
Cancers|July 12, 2025
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic CenterFrancesco Grimaldi, Mara Memoli, Simona Avilia, et al.
International Journal of Environmental Research and Public Health|November 13, 2021
<i>Pneumocystis jirovecii</i> Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center ExperienceIvan Gentile, Giulio Viceconte, Amedeo Lanzardo, et al.
Medical Mycology|February 13, 2019
Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannanMalgorzata Mikulska, Elisa Furfaro, Elena De Carolis, et al.
Journal of Clinical Medicine|December 19, 2020
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the IcebergNicola Capasso, Raffaele Palladino, Emma Montella, et al.
The New Microbiologica|April 30, 2019
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohortIvan Gentile, Antonio Riccardo Buonomo, Carmine Coppola, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 22, 2026
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort StudyAntonella d'Arminio Monforte, Nicolò Lentini, Alessandro Tavelli, et al.
Vaccines|December 23, 2022
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, et al.
Pageof 8